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Edited by Ivan SadowskiAbstract Nucleophosmin (NPM) is a multifunctional phospho-
protein, being involved in ribosome assembly, pre-ribosomal
RNA processing, DNA duplication, nucleocytoplasmic protein
traﬃcking, and centrosome duplication. NPM is phosphorylated
by several kinases, including nuclear kinase II, casein kinase 2,
Polo-like kinase 1 and cyclin-dependent kinases (CDK1 and
2), and these phosphorylations modulate the activity and function
of NPM. We have previously identiﬁed Thr199 as the major phos-
phorylation site of NPM mediated by CDK2/cyclin E (and A),
and this phosphorylation is involved in the regulation of centro-
some duplication. In this study, we further examined the eﬀect
of CDK2-mediated phosphorylation of NPM by using the anti-
body that speciﬁcally recognizes NPM phosphorylated on
Thr199. We found that the phospho-Thr199 NPM localized to dy-
namic sub-nuclear structures known as nuclear speckles, which
are believed to be the sites of storage and/or assembly of pre-
mRNA splicing factors. Phosphorylation on Thr199 by CDK2/cy-
clin E (and A) targets NPM to nuclear speckles, and enhances
the RNA-binding activity of NPM. Moreover, phospho-Thr199
NPM, but not unphosphorylated NPM, eﬀectively represses
pre-mRNA splicing. These ﬁndings indicate the involvement of
NPM in the regulation of pre-mRNA processing, and its activity
is controlled by CDK2-mediated phosphorylation on Thr199.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Nucleophosmin (NPM), also known as B23, NO38 or numa-
trin, is a multifunctional phosphoprotein, and has been impli-
cated in a wide variety of cellular events, including ribosome
assembly and pre-ribosomal RNA processing in nucleolus
[1–4], DNA duplication [5–7], nucleocytoplasmic protein traf-
ﬁcking through directly binding to the nuclear localization sig-
nals (NLS) of the target proteins [8–11], and centrosome
duplication [12,13]. In addition, NPM has been shown to pos-
sess interesting properties, including RNA-binding and molec-
ular chaperoning activities [14–17]. NPM is phosphorylated by
several diﬀerent kinases, including casein kinase 2 (CK2), nu-*Corresponding author. Fax: +1 513 558 4454.
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dent kinases (CDK1/cyclin B, CDK2/cyclin E, and CDK2/
cyclin A) [12,13,17–22]. Phosphorylation by CK2 increases
NPM’s aﬃnity to the NLS sequences derived from the SV40
large T antigen and the HIV Rev protein [10,11] as well as
to modulate its molecular chaperoning activity, especially for
its interaction with target proteins [21]. Phosphorylation of
NPM on Ser4 by PLK1 has been shown to play a role in nu-
meral homeostasis of centrosomes as well as cytokinesis [22].
Phosphorylation by CDK2/cyclin E (and A) on Thr199 of
NPM is critical for the regulation of centrosome duplication
by aﬀecting its binding aﬃnity to centrosomes [13].
It has been shown that NPM binds and alters the secondary
structure of RNA [15,17]. Moreover, the RNA-binding activity
of NPM is controlled by phosphorylation. For instance, CDK1/
cyclin B phosphorylates NPM on several residues, which results
in a decrease in the RNA-binding aﬃnity of NPM [17]. These
observations suggest the role of NPM in RNA transcription,
metabolism, and/or processing. Indeed, NPM was co-puriﬁed
from HeLa cell nuclear extracts with general splicing activator
RNPS1, which physically interacts with serine/arginine-rich
(SR) splicing factors, pinin, human Tra2b, and CK2 to regulate
splicing in vivo [23–25], suggesting its potential association with
pre-mRNA splicing. Pre-mRNA splicing occurs in a macromo-
lecular complex known as the spliceosome, which consists of ﬁve
small nuclear ribonuclear particles (snRNPs) and a large num-
ber of non-snRNP protein splicing factors (reviewed in
[26,27]). The phosphorylation state of splicing factors appears
to be critical for at least two events during the pre-mRNA splic-
ing process; (1) spliceosome formation and (2) selection of pre-
mRNA splice sites (reviewed in [28]). Pre-mRNA splicing fac-
tors are mostly conﬁned to 20–50 irregularly shaped nuclear
speckles within the nucleoplasm, which are believed to be the
sites of storage and/or assembly of pre-mRNA splicing factors
(reviewed in [29]). Ultrastructural studies have revealed that
the nuclear speckles consist of interchromatin granule clusters
(IGCs) and perichromatin ﬁbrils (PFs) (reviewed in [30,31]).
IGCs are composed of particles measuring 20–25 nm in diame-
ter, and they contain numerous factors that are involved in
mRNA synthesis and processing. IGC constituents include
small nuclear ribonucleoprotein particles (snRNPs), SR splicing
factors, and hyperphosphorylated form of the large subunit of
RNApolymerase II [32]. Despite the presence of splicing factors
in IGCs, pre-mRNA processing does not occur within these
structures, but rather at PFs, which are found at the periphery
of or at some distance away from IGCs [33].blished by Elsevier B.V. All rights reserved.
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cance of the Thr199 phosphorylation of NPM in cellular event(s)
other than centrosome duplication by the use of the antibody
that speciﬁcally recognizes NPM phosphorylated on Thr199
(phospho-Thr199 NPM). We found that phospho-Thr199 NPM
localizes at nuclear speckles. As expected from the cell cycle
phase-speciﬁc activation of CDK2/cyclin E as well as CDK2/cy-
clin A, appearance of phospho-Thr199 NPM occurs in a cell cy-
cle-dependent manner. Moreover, CDK2/cyclin E-mediated
phosphorylation of NPM signiﬁcantly enhances its RNA-bind-
ing aﬃnity, and represses pre-mRNA splicing in vitro. These
ﬁndings suggest the involvement of NPM in the regulation of
pre-mRNA processing, which is modulated by CDK2/cyclin E
(and A)-mediated phosphorylation on Thr199.2. Materials and methods
2.1. Cell and transfection
Wild-type mouse skin ﬁbroblasts (MSFs) were prepared from
abdominal skins of an 8-week-old C57L male mouse, and maintained
in complete medium [DMEM supplemented with 10% fetal bovine ser-
um (FBS), penicillin (100 U/ml) and streptomycin (100 lg/ml)] in an
atmosphere containing 10% CO2. Plasmid transfection was performed
using Fugene 6 reagent (Roche).
2.2. Antibodies
Anti-pan NPM mouse monoclonal antibody is a gift from Dr. P.K.
Chan (Baylor College of Medicine). Anti-phospho-Thr199 rabbit poly-
clonal antibody (Cell Signaling Technology) was generated against a
synthetic phospho-peptide around Thr199 of human NPM. The anti-
bodies were puriﬁed by protein A and aﬃnity chromatography.
Anti-cyclin E (M-20), anti-cyclin A (C-19), anti-cyclin B (SC-55),
anti-hnRNP I and anti-SF2/ASF antibodies were purchased from
Santa Cruz Biotechnology. Anti-FLAG (M2) and anti-a-tubulin
(DM1A) antibodies were purchased from Sigma Immunochemicals.
Anti-T7-tag antibody was purchased from Novagen. Generation of
mouse anti-SC35 antibody was previously described [34].
2.3. Immunoblot analysis
Cells were washed three times with PBS and lysed in SDS/NP-40 ly-
sis buﬀer [1% SDS, 1% NP-40, 50 mM Tris (pH 8.0), 150 mM NaCl,
4 mM Pefabloc SC (Roche), 2 lg/ml leupeptin, 2 lg/ml aprotinin].
The lysates were boiled for 5 min, and cleared by a 10 min centrifuga-
tion at 20000 · g at 4 C. The supernatant was denatured at 95 C for
5 min in sample buﬀer [2% SDS, 10% glycerol, 60 mM Tris (pH 6.8),
5% b-mercaptoethanol, 0.01% bromophenol blue]. Samples were re-
solved by SDS–PAGE, and transferred onto Immobilon-P sheets (Mil-
lipore). The blots were incubated in blocking buﬀer [5% (wt/vol) non-
fat dry milk in Tris-buﬀered saline (TBS) + Tween 20 (TBS-T)] for 1 h
at room temperature. The blots were incubated with primary antibody
for overnight at 4 C, followed by incubation with horseradish perox-
idase-conjugated secondary antibody for 1 h at room temperature. The
antibody-antigen complex was visualized by ECL chemiluminescence
(Amersham Biosciences).
2.4. Indirect immunoﬂuorescence
Cells grown on coverslips were ﬁxed with 10% formalin/10% metha-
nol for 20 min at room temperature. The cells were permeabilized with
1% NP-40 in PBS for 5 min, followed by incubation with blocking solu-
tion [10% normal goat serum in PBS] for 1 h. Cells were then probed
with primary antibodies for 1 h, and antibody-antigen complexes were
detected with either Alexa Fluor 488- or Alexa Fluor 594-conjugated
goat secondary antibody (Molecular Probes) by incubation for 1 h at
room temperature. The coverslips were washed three times with PBS
after each incubation, and then counterstained with 4 0,6-diamidino-2-
phenylindole (DAPI). Immunostained cells were examined under a
ﬂuorescence microscope (Zeiss Axioplan 2 Imaging, 60· objective lens)
or confocal microscope (Zeiss LSM510, 63· objective lens).2.5. In vitro kinase assay
GST, GST-NPM/wt, or GST-NPM/T199A were incubated with
baculovirally puriﬁed active CDK2/cyclin E [35] or CK2 (New Eng-
land Biolabs). The enzymatic activities of both CDK2/cyclin E and
CK2 were conﬁrmed by in vitro kinase reactions in the presence of
[c-32P]ATP using GST-NPM/wt as a substrate. The in vitro kinase
reactions were performed in 10 mM PIPES buﬀer in the presence of
ATP at 32 C for 30 min. The reaction samples were resolved by
SDS–PAGE.
2.6. Alkaline phosphatase treatment
Cells grown on coverslips were ﬁxed with 100% methanol for 10 min
at 20 C. Cells were then air-dried, and re-hydrated in PBS for
10 min at room temperature. Cells were incubated in the solution
[100 mM glycine (pH 10.4)] containing 10 units of alkaline phospha-
tase type IV (Sigma) for 2 h at 37 C. The control cells were incubated
in the solution without alkaline phosphatase.
2.7. RNA binding assay
The assay was performed as previously described [17]. Brieﬂy, RNA
was extracted from MSFs using TRIZOL (Gibco BRL). GST-NPM
proteins were subjected to an in vitro kinase assay with CDK2/cyclin
E, and mixed with RNA for 30 min at room temperature. The samples
were loaded onto 15–40% sucrose gradient [20 mM Tris (pH 7.4),
50 mM NaCl, 0.5 mM PMSF, and 1 mM dithiothreitol], centrifuged
at 39000 rpm for 4 h, and fractions were collected from the bottom.
The fractions were resolved in 10% SDS–PAGE for immunoblot anal-
ysis, and on 1% agarose-formaldehyde gel electrophoresis for Northern
blot analysis using 32P-labeled 18S rRNA DNA probe (Ambion).
2.8. Northwestern analysis
Bacterially puriﬁed GST, GST-NPM/wt, GST-NPM/T199A, or
GST-NPM/T199D proteins were phosphorylated with CDK2/cyclin
E, and re-puriﬁed. The proteins were separated by SDS–PAGE and
transferred to a membrane. The membrane was blocked with 5%
non-fat dry milk in RNA-binding buﬀer (RBB) [20 mM Tris–HCl
(pH 7.5), 60 mM KCl, 1 mM MgCl2, 0.2 mM EDTA, 10% glycerol]
containing 2 lg/ml yeast tRNA for 1 h, and then incubated in the
RBB containing 0.25% non-fat dry milk, 2 lg/ml yeast tRNA, 1 U/
ml RNase inhibitor, and 32P-labeled b-globin pre-mRNA for 16 h.
The membrane was washed, air-dried, and autoradiographed.
2.9. In vitro splicing assay
The m7GpppG-capped 32P-labeled pre-mRNA was made by run-oﬀ
transcription of linearized b-globin template DNA with SP6 RNA
polymerase, which was used as a substrate for in vitro splicing assay
in HeLa cell nuclear extract [36]. Bacterially puriﬁed GST, GST-
NPM/wt, GST-NPM/T199A, or GST-NPM/T199D proteins were
phosphorylated with CDK2/cyclin E, and re-puriﬁed. The mock or
CDK2/cyclin E phosphorylated GST, GST-NPM/wt, GST-NPM/
T199A, or GST-NPM/T199D was added to splicing reactions (in
25 ll) with 20 fmol of 32P-labeled b-globin pre-mRNA and incubated
at 30 C for 2–3 h. The spliced products were analyzed by denaturing
5.5% PAGE and autoradiography.3. Results
3.1. NPM phosphorylated on Thr199 localizes in a speckled
pattern in the nuclei
NPM is phosphorylated on Thr199 primarily by CDK2/cy-
clin E and A, and this phosphorylation is important in the reg-
ulation of centrosome duplication [13]. Since centrosome
duplication occurs in coordination with other cell cycle events,
and NPM is involved in a variety of cellular events, it is possi-
ble that CDK2-mediated phosphorylation of NPM may aﬀect
more than one cellular event. To test this possibility, we
obtained an antibody, which was generated against phospho-
Thr199 of NPM. We ﬁrst tested the speciﬁcity of the anti-phos-
pho-Thr199 NPM antibody. The bacterially puriﬁed wild-type
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an in vitro kinase assay with CDK2/cyclin E. Since CK2 has
been shown to be another major kinase that phosphorylates
NPM on the residues other than Thr199 [21], in vitro kinase
reaction was also performed with CK2 as a control. We also
included a NPM mutant whose Thr199 residue was replaced
with Ala (GST-NPM/T199A) as well as GST alone as controls.
The reaction samples were immunoblotted using phospho-
Thr199 NPM antibody (Fig. 1A, panel a). The same blot was
stained with Coomassie blue (panel b), showing that all reac-Fig. 1. Phospho-Thr199 NPM is distributed in a speckled pattern within the
Wild-type and Ala-substitution mutant NPM fused to GST (GST-NPM/wt an
to an in vitro kinase assay with either CK2 or CDK2/cyclin E. The reactions
Thr199 NPM antibody (left panel). Coomassie blue staining of the same gel is
cyclin E was detected by anti-phospho-Thr199 NPM antibody (lane 8), dem
immunostained with either anti-panNPM monoclonal (panels a–c) or anti-ph
depicted by diﬀerential interference contrast microscopy (indicated by arrow
10 lm. (C) After ﬁxation, cells were treated with alkaline phosphatase (AP) (
alkaline phosphatase. The AP-treated (panels c and d) and mock-treated MSF
NPM antibody (panels a and c). Cells were also stained for DNA with DAP
antibody no longer detected the speckled pattern of signals (panel c). Scaletion samples contain similar levels of either GST-NPM/wt or
GST-NPM/T199A. GST-NPM/wt phosphorylated by CDK2/
cyclin E was readily detected by the anti-phospho-Thr199
NPM antibody (lane 8). It should be noted that the GST-
NPM/wt phosphorylated by CDK2/cyclin E showed a slightly
faster migration than the unphosphorylated form (lane 17),
which is consistent with the previous observation [12]. In
contrast to wild-type GST-NPM, neither GST (lane 7) nor
GST-NPM/T199A (lane 9) was recognized by the anti-phos-
pho-Thr199 NPM antibody. Phosphorylation of GST-NPM/nucleus. (A) Characterization of anti-phospho-Thr199 NPM antibody.
d GST-NPM/T199A, respectively) as well as GST alone was subjected
were resolved in SDS–PAGE and immunoblotted using anti-phospho-
shown in the right. Only the wild-type NPM phosphorylated by CDK2/
onstrating the speciﬁcity of this antibody. (B) MSFs were ﬁxed and
ospho-Thr199 NPM polyclonal (panels d–f) antibodies. The nucleoli are
s, panels b and e). Panels c and f show the overlay images. Scale bar:
see Section 2). The control cells were incubated in the solution without
s (panels a and b) were then immunostained with anti-phospho-Thr199
I (panels b and d). In the AP-treated cells, anti-phospho-Thr199 NPM
bar: 10 lm.
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tected by this antibody. Thus, the anti-phospho-Thr199 NPM
antibody is speciﬁc to NPM phosphorylated on Thr199 by
CDK2.
We next examined whether phospho-Thr199 NPM shows any
speciﬁc subcellular localization by immunostaining primary
skin ﬁbroblasts (MSFs) derived from adult mice with the
anti-phospho-Thr199 NPM antibody. We also immunostained
MSFs with anti-panNPM monoclonal antibody raised against
a puriﬁed NPM protein, which reacts with both phosphory-
lated and non-phosphorylated forms of NPM [12]. The anti-
panNPM antibody detected NPM primarily in the nucleolus
and to lesser extent in the nucleoplasm as scattered small
dot-like structures (Fig. 1B, panels a–c). In contrast, anti-
phospho-Thr199 NPM antibody did not detect NPM in the
nucleolus, but detected NPM in distinct intranuclear structures
(speckles) as well as in diﬀuse regions throughout the nucleo-
plasm (Fig. 1B, panels d–f). The speckles detected by the
anti-phospho-Thr199 NPM antibody are clearly distinct from
nucleoli that are visualized in the diﬀerential interference con-
trast (DIC) image of the cell (Fig. 1B, panel e, nucleoli are indi-
cated by arrows).
To further conﬁrm the speciﬁcity of the immunostaining pat-
tern of the anti-phospho-Thr199 NPM antibody, we treated the
ﬁxed MSFs with alkaline phosphatase and immunostained
with the anti-phospho-Thr199 NPM antibody. The control un-
treated MSFs (Fig. 1C, panel a) showed the speckled as well as
the diﬀuse staining pattern similar to the cell shown in Fig. 1B
(panel d). However, the anti-phospho-Thr199 NPM antibody
failed to detect antigens in the alkaline phosphatase-treated
cells, demonstrating that this antibody is indeed detecting the
phosphorylated epitope (Fig. 1C, panel c).3.2. Kinetic analysis of phospho-Thr199 NPM during the cell
cycle
Since CDK2/cyclin E is activated during late G1 phase of the
cell cycle, we tested the changes in the levels of phospho-Thr199
NPM during the cell cycle. We ﬁrst synchronized MSFs by ser-
um starvation, followed by serum stimulation. At every 5 h
after serum-stimulation for a period of 20 h, cells were ﬁxed
and examined by anti-phospho-Thr199 NPM immunostaining
(Fig. 2A). To monitor the cell cycle progression, cells were cul-
tured in parallel in the presence of BrdU (Fig. 2C). Under a
serum-starved condition, there was little or no phospho-
Thr199 NPM staining as expected. Between 5 and 10 h after
serum stimulation, weak yet detectable signals of phospho-
Thr199 NPM staining were observed in some cells. At 20 h,
strong signals of phospho-Thr199 NPM staining were detected
in the majority of cells. To quantitate the cell cycle-dependent
emergence of phospho-Thr199 NPM, the images taken by laser
scanning confocal microscopy were subjected to the computa-
tional morphometric measurements (Fig. 2B). The intensity of
the phospho-Thr199 NPM signals gradually increased during
serum stimulation, and importantly the rate of the increase
was closely parallel to the rate of BrdU incorporation
(Fig. 2C). Considering that CDK2/cyclin E is activated prior
to S phase entry, these results indicate that appearance of
phospho-Thr199 NPM in the nuclear speckle pattern is medi-
ated by activated CDK2/cyclin E.
To corroborate the above observations, we examined the
phospho-Thr199 NPM protein level in MSFs after serum stim-ulation by immunoblot analysis (Fig. 2D, top panel). At 0 h,
no phospho-Thr199 NPM was detected. As the cell cycle pro-
gressed (5, 10, 15 h), we detected low levels of phospho-
Thr199 NPM. At 20 h of serum stimulation, the level of phos-
pho-Thr199 NPM increased dramatically. These results are
consistent with the changes in the level of phospho-Thr199
NPM during G1 progression observed immunocytochemically.
The changes in the level of phospho-Thr199 NPM was not due
to the changes in the overall NPM protein level, since immuno-
blot analysis using anti-panNPM antibody showed no signiﬁ-
cant change in the total NPM protein level during 20 h of
serum stimulation (Fig. 2D, bottom panel).
The level of phospho-Thr199 NPM did not saturate and con-
tinued to increase at 20 h of serum stimulation, while 80% of
the cells had entered S-phase (Fig. 2B and C). Because CDK2/
cyclin E activation peaks at G1/S transition, the failure to sat-
urate NPM phosphorylation on Thr199 raises the possibility
that kinase(s) other than CDK2/cyclin E may also catalyze
the phosphorylation of NPM on Thr199. Since CDK2/cyclin
A can phosphorylate NPM on Thr199 [13] and CDK2/cyclin
A activation occurs during S-phase [37], it is possible that
CDK2/cyclin A may be responsible for continuous phosphor-
ylation of NPM on Thr199. To test this, the lysates prepared
from cells at every 5 h for a total of 20 h during serum-stimu-
lation were subjected to immunoblot analysis using anti-cyclin
E, anti-cyclin A, and anti-cyclin B antibodies (Fig. 2E). The le-
vel of cyclin E peaked at 15 h (top panel), while the increase in
the level of cyclin A was detected between 15 and 20 h (second
panel), indicating that CDK2/cyclin E initiates phosphoryla-
tion of NPM on Thr199, and CDK2/cyclin A may take over
Thr199 phosphorylation of NPM in late G1 and S. Cyclin B
was not detectable at 20 h (third panel), indicating that
CDK1/cyclin B is not responsible for generation of the anti-
phospho-Thr199 NPM antibody epitope at 20 h during ser-
um-stimulation. Indeed, it has been shown that CDK1/cyclin
B phosphorylates NPM on the residues other than Thr199 [13].3.3. Phospho-Thr199 NPM localizes to nuclear speckles
The unique sub-nuclear localization of phospho-Thr199
NPM prompted us to search for other nuclear proteins with
similar localization patterns. The pre-mRNA splicing machin-
ery, which primarily consists of small nuclear ribonucleopro-
tein particles (snRNPs) and many non-snRNP protein
factors, is known to sub-nuclearly localize in a speckle pattern
known as ‘‘nuclear speckles’’ [29]. A member of SR protein
family SC35, a non-snRNP spliceosome component that is
essential for spliceosome assembly and function, has been used
as a marker protein for identifying nuclear speckles [38,39]. We
noticed that the immunostaining pattern of SC35 shown in
previous studies resembles that of phospho-Thr199 NPM. In
addition, biochemical co-puriﬁcation of NPM along with
splicing activator RNPS1 from HeLa cell nuclear extracts
[25] raises the possibility that phospho-Thr199 NPM may local-
ize to nuclear speckles. To test this possibility, we co-immuno-
stained MSFs with anti-phospho-Thr199 NPM and anti-SC35
antibodies (Fig. 3A). We found that phospho-Thr199 NPM
co-localized to many of the speckles identiﬁed by anti-SC35
antibody. Similarly, we found co-localization of the transiently
transfected T7-tagged RNPS1 and phospho-Thr199 NPM in a
speckled pattern (Fig. 3B). These results demonstrate that
NPM localizes to nuclear speckles, and co-localization of
Fig. 2. Cell-cycle dependent changes in the level of phospho-Thr199 NPM. (A) MSFs were serum starved for 48 h, followed by serum stimulation
with medium containing 20% FBS. At indicated time points, cells were immunostained using anti-phospho-Thr199 NPM antibody. (B) The
immunostained images taken by confocal microscopy in A were quantitated for phospho-Thr199 NPM signals by integrated morphometry analysis
using Metamorph software program (Universal Imaging Corp.). (C) In parallel, MSFs were examined for BrdU incorporation using the BrdU-
labeling kit (Roche). After serum starvation for 48 h, MSFs were serum stimulated with medium containing 20% FBS in the presence of BrdU. MSFs
were then immunostained with anti-BrdU antibody. The rate of BrdU incorporation was determined by examining >300 cells. (D) MSFs were serum
starved for 48 h, followed by serum stimulation. The whole cell lysates were prepared at indicated time points and immunoblotted with anti-phospho-
Thr199 NPM antibody (top panel) as well as anti-panNPM antibody (bottom panel). It should be noted that the running condition of the SDS–
PAGE in this analysis does not allow the band separation of phosphorylated and unphosphorylated NPM by anti-panNPM antibody. (E) The
lysates described above in (D) were immunoblotted with anti-cyclin E (top panel), anti-cyclin A (second panel) and anti-cyclin B (third panel)
antibodies. As a loading control, the lysates were immunoblotted with anti-a-tubulin antibody.
P. Tarapore et al. / FEBS Letters 580 (2006) 399–409 403
Fig. 3. Phospho-Thr199 NPM localizes at nuclear speckles. (A) Phospho-Thr199 NPM co-localizes with SC35 at nuclear speckles. MSFs under an
optimal growth condition were co-immunostained with rabbit anti-phospho-Thr199 NPM (panel a) and mouse anti-SC35 (panel b) antibodies.
Antigen-antibody complexes were detected with Alexa Fluor 488 goat anti-rabbit IgG (green) and Alexa Fluor 594 goat anti-mouse IgG (red)
antibodies. Panel c is the overlay image, showing a high degree of co-localization of phospho-Thr199 NPM and SC35. Scale bar: 10 lm. (B) Phospho-
Thr199 NPM co-localizes with RNPS1 at nuclear speckles. MSFs were transiently co-transfected with a plasmid encoding T7 epitope-tagged RNPS1
and a plasmid encoding a puromycin resistance gene (pBabe/puro) at a molar ratio of 20:1. The puromycin-resistant cells were pooled and replated
on coverslips and further cultured in fresh complete medium for 24 h. Cells were then co-immunostained with rabbit anti-phospho-Thr199 NPM
(panel a) and mouse anti-T7 tag (panel b) antibodies. Antigen-antibody complexes were detected as described in (A). The co-localization of phospho-
Thr199 NPM and RNPS1 was detected as yellow color in the overlay image (panel c). Scale bar: 10 lm. (C) Co-migration of phospho-Thr199 NPM
and SC35 to enlarged speckles upon inhibition of transcription. MSFs were treated with a-amanitin (50 lg/ml) for 5 h. The control MSFs were
untreated. Cells were then ﬁxed and immunostained with anti-phospho-Thr199 NPM and anti-SC35 antibodies as described above. The nuclei were
also counterstained with DAPI (panels d and h). Panels c and g are the overlay images. In control cells, phospho-Thr199 NPM (panel a) and SC35
(panel b) distributed in a speckled pattern along with a diﬀuse staining. In contrast, in a-amanitin treated cells, both phospho-Thr199 NPM and SC35
redistributed to enlarged and rounded speckles. Scale bar: 10 lm.
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potential role of NPM in pre-mRNA processing.
Nuclear speckles are structurally dynamic, changing the con-
stituent proteins depending on the transcription activity of the
cell. Upon transcription activation, pre-mRNA splicing factors
such as SC35 are recruited from interchromatin granule clus-
ters (IGC) to perichromatin ﬁbrils (PF) [40–42]. Thus, inhibi-
tion of transcription leads to a sub-nuclear redistribution of
proteins involved in pre-mRNA processing and splicing fac-
tors including SC35. For instance, administration of RNA
polymerase II inhibitor a-amanitin, which is commonly used
for inhibition of transcription, results in appearance of en-
larged rounded speckles of splicing factors and disappearance
of diﬀuse connections between the speckles in the nucleoplasm
[43,44]. To obtain further evidence for the nuclear speckle
localization of phospho-Thr199 NPM, we tested whether phos-
pho-Thr199 NPM would redistribute to enlarged speckles upon
transcription inhibition along with SC35. To this end, MSFswere treated with a-amanitin, and co-immunostained with
anti-phospho-Thr199 NPM and anti-SC35 antibodies. In the
control untreated cells, we observed the co-localized speckle
patterns of SC35 and phospho-Thr199 NPM along with diﬀuse
staining (Fig. 3C, panels a–d). In the a-amanitin treated cells,
as described previously [44], SC35 redistributed to enlarged
rounded speckles and diﬀuse staining was no longer detected
(panel f). We found that the phospho-Thr199 NPM redistrib-
uted together with SC35 to enlarged rounded speckles without
any diﬀuse staining (panels e and g), demonstrating that NPM
phosphorylated on Thr199 re-localizes along with other pre-
mRNA processing factors, further indicating the potential
involvement of NPM in pre-mRNA processing.
3.4. Thr199 phosphorylation targets NPM to nuclear speckles
As shown in Fig. 2A, phospho-Thr199 NPM is not found in
the speckles in the serum-starved cells, but gradually accumu-
lates during G1 and S progression. This observation raises the
P. Tarapore et al. / FEBS Letters 580 (2006) 399–409 405question of whether CDK2-mediated phosphorylation of
NPM occurs at nuclear speckles or CDK2-mediated phos-
phorylation targets NPM to nuclear speckles. To address this
question, we transiently transfected FLAG-tagged non-phos-
phorylatable mutant NPM (NPM/T199A) and phospho-mi-
metic mutant NPM (NPM/T199D) into MSFs. As a control,
a FLAG vector was transfected. The transfectants were immu-
nostained with anti-FLAG and anti-SC35 antibodies (Fig. 4).
No speciﬁc immunostaining by anti-FLAG antibody was ob-
served in the vector-transfected cells (panels a–d). We found
that the FLAG-T199A mutant failed to localize to the nuclear
speckles detected by anti-SC35 antibody, but rather uniformly
distributed within the nucleus with slightly more accumulation
in nucleolus (panels e–h). In contrast, FLAG-T199D was more
concentrated at typical nuclear speckles detected by anti-SC35
antibody (panels i–l). These results strongly indicate that
Thr199 phosphorylation targets NPM to the speckle, and thus
NPM translocates to the nuclear speckles upon Thr199 phos-
phorylation by CDK2/cyclin E (and A) during G1 progression
and S-phase.
3.5. CDK2/cyclin E-mediated phosphorylation enhances the
RNA-binding activity of NPM
Among the non-snRNP spliceosomal proteins, the members
of the SR protein family (10 authentic human SR proteinsFig. 4. Thr199 phosphorylation targets NPM to nuclear speckles. (A) M
phosphorylatable mutant NPM (NPM/T199A) or phospho-mimetic mutant
The transfectants were co-immunostained with rabbit anti-FLAG and mouse
Alexa Fluor 488 goat anti-rabbit IgG (green) and Alexa Fluor 594 goat anti
with DAPI. Panels 1–9 show the magniﬁed images of the area indicated byhave been identiﬁed to date) have been well characterized
[45,46]. It has been shown that the RNA-binding activities of
some SR proteins are modulated by phosphorylation [47–50].
Since NPM also possesses a RNA-binding activity [15–17],
we examined whether Thr199 phosphorylation aﬀects the
RNA-binding activity of NPM. GST-NPM/wt and GST-
NPM/T199A were subjected to an in vitro kinase assay with
CDK2/cyclin E, and then incubated with total RNA extracted
fromMSFs. The reaction samples were subjected to a standard
sucrose gradient sedimentation assay used for determination of
general RNA binding of the protein. GST-NPM/wt alone and
GST-NPM/wt subjected to a mock kinase reaction, were in-
cluded as controls. The resulting fractions were collected and
the total RNA elution proﬁles were determined. The RNA elu-
tion pattern of the control reaction (without GST-NPM and
CDK2/cyclin E) is shown in the top panel of Fig. 5A. The
RNA elution patterns of all the reaction samples were virtually
identical to that of the control reaction. The same fractions
were examined for NPM by immunoblot analysis. There was
no signiﬁcant diﬀerence in the elution patterns of NPM among
GST-NPM/wt alone, non-phosphorylated GST-NPM/wt incu-
bated with RNA, and GST-NPM/T199A after in vitro kinase
reaction with CDK2/cyclin E (Fig. 5A, top three panels, frac-
tions 2–8). In contrast, the phosphorylated GST-NPM/wt was
eluted in fractions 2–10, demonstrating that CDK2-mediatedSFs were transiently transfected with either FLAG-tagged non-
NPM (NPM/T199D). The FLAG vector was transfected as a control.
anti-SC35 antibodies. Antigen-antibody complexes were detected with
-mouse IgG (red) antibodies. Cells were also counterstained for DNA
arrows. Scale bar: 10 lm.
Fig. 5. Thr199 phosphorylation enhances the RNA-binding activity of NPM, and phospho-Thr199 NPM represses in vitro pre-mRNA splicing. (A) CDK2-mediated
phosphorylation on Thr199 enhances the RNA-binding activity of NPM. GST-NPM/wt and GST-NPM/T199A were subjected to an in vitro kinase assay with CDK2/
cyclin E and incubated in the absence or presence of total RNA prepared from MSFs. The reaction samples were subjected to a 15–40% sucrose gradient fractionation,
and the fractions were collected from the bottom of the tube. RNA as well as RNA/protein complexes were precipitated from each fraction. RNA from each fraction was
resolved by 1% agarose-formaldehyde gel and probed for 18S rRNA (Ambion). It should be noted that probing for18S rRNA is a standard protocol with this
experimental procedure to determine the elution proﬁle of total RNA. The intensity of each band from the Northern blot was quantiﬁed using Metamorph software. The
graph shown in the top is of the elution pattern of the total RNA without addition of neither NPM nor CDK2/cyclin E. The RNA elution patterns of all the reaction
samples were virtually identical to that without reaction shown in the graph. Each fraction was then subjected to immunoblot analysis using anti-panNPM antibody
(bottom four panels). The arrows point to the fractions showing apparent diﬀerences in the RNA-binding activity of NPM upon CDK2/cyclin E-mediated
phosphorylation. (B) GST-NPM/wt proteins that were subjected to kinase reactions in the presence or absence of CDK2/cyclin E, as well as GST, GST-NPM/T199A and
GST-NPM/T199D subjected to kinase reactions in the presence of CDK2/cyclin E were resolved in SDS–PAGE, and transferred to membrane. The membrane was then
blotted with 32P-labeled b-globin pre-mRNA, and autoradiographed. (C) NPM physically interacts with splicing factors. The HeLa nuclear extracts were
immunoprecipitated with anti-hnRNP I and anti-SF2/ASF antibodies. As a control, the extracts were immunoprecipitated with anti-viral gag protein antibody. The
immunoprecipitates were immunoblotted with anti-panNPM antibody. As a reference, 5% of the extracts used for immunoprecipitation were included in the immunoblot
analysis. (D) Phospho-Thr199 NPM represses in vitro pre-mRNA splicing. 32P-labeled b-globin pre-mRNA was incubated with HeLa nuclear extract and indicated
amounts of GST, GST-NPM/wt, GST-NPM/T199A or GST-NPM/T199D subjected to kinase reactions either in the presence or absence of CDK2/cyclin E. The spliced
products were analyzed by 5.5% polyacrylamide/7 M urea gel, and autoradiographed. As controls, 32P-labeled b-globin pre-mRNA samples without splicing reaction
(lane 1) and with splicing reaction without addition of GST or GST-fusion proteins (lane 2) were included. The experiment was repeated three times, and obtained similar
results in all the experiments.
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binding aﬃnity (bottom panel). It should be noted here that
the elution of NPM in the wide fraction range probably reﬂects
the property of NPM to oligomerize [51,52]. However, CDK2-
mediated phosphorylation does not appear to aﬀect the ability
of NPM to oligomerize (P. Tarapore, unpublished observa-
tion), and thus the changes in the elution pattern of in vitro
phosphorylated NPM is not due to the changes in its oligomer-
ization property.
To corroborate the above ﬁnding, we performed Northwest-
ern blot analysis of GST-NPM/wt with or without kinase reac-
tion with CDK2/cyclin E as well as GST-NPM/T199A and
GST-NPM/T199D mutants using the 32P-labeled b-globin
pre-mRNA as a probe (Fig. 5B). The unphosphorylated
GST-NPM/wt failed to bind to the probe (lane 2), while
GST-NPM/wt phosphorylated by CDK2/cyclin E were readily
detected by the probe (lane 3). Similarly, GST-NPM/T199A
non-phosphorylatable mutant failed to bind to the probe (lane
4), while GST-NPM/T199D phospho-mimetic mutant eﬃ-
ciently bound to the probe (lane 5). These results further indi-
cate that the RNA-binding activity of NPM is greatly
enhanced by CDK2-mediated phosphorylation on Thr199.
3.6. Repression of pre-mRNA splicing by NPM phosphorylated
on Thr199
It has been shown that phosphorylation/dephosphorylation
plays a critical role in the regulation of the activities of proteins
involved in pre-mRNA splicing [47–50]. We have shown that
(i) NPM localizes to nuclear speckles likely as a part of splice-
osome complexes, (ii) Thr199 phosphorylation targets NPM to
nuclear speckles, and (iii) Thr199 phosphorylation enhances the
RNA-binding activity of NPM. Moreover, it has been shown
that NPM is co-puriﬁed with splicing activator RNPS1 in
the highly puriﬁed fractions from HeLa nuclear extracts [25].
All these ﬁndings converge to one hypothesis that NPM may
be involved in pre-mRNA splicing, and such activity may be
controlled by Thr199 phosphorylation. To test this, we ﬁrst
examined the physical interaction between NPM and splicing
factors other than RNPS1. The HeLa nuclear extracts were
immunoprecipitated with antibodies to hnRNP I and SF2/
ASF. The immunoprecipitates were then immunoblotted with
anti-panNPM antibody (Fig. 5C). NPM was co-immunopre-
cipitated with both hnRNP I (lane 1) and SF2/ASF (lane 2),
indicating that NPM either directly or indirectly interact with
these splicing factors.
We next examined the eﬀect of phosphorylated NPM on pre-
mRNA splicing in vitro. GST, GST-NPM/wt, GST-NPM/
T199A and GST-NPM/T199D, which were subjected to
in vitro kinase reaction in the presence or absence of CDK2/cy-
clin E, were added to HeLa nuclear extract, and subjected to an
in vitro splicing assay using b-globin pre-mRNA as a substrate
(Fig. 5D). Similar levels of theb-globin pre-mRNAsplicedprod-
uct were detected among the control (no GST proteins) (lane 2),
GST (lanes 3–6), andunphosphorylatedGST-NPM/wt (lanes 7–
8). However, a signiﬁcant repression in b-globin pre-mRNA
splicing was detected when the GST-NPM/wt phosphorylated
by CDK2/cyclin E was added (lane 10). Similarly, addition of
the non-phosphorylatable GST-NPM/T199A mutant (with the
kinase reaction in the presence or absence of CDK2/cyclin E)
failed to repress pre-mRNA splicing (lanes 11–14), while addi-
tion of the phospho-mimetic GST-NPM/T199D mutant re-
sulted in the strong repression of pre-mRNA splicing (lanes 16and 18). Moreover, repression of pre-mRNA splicing by phos-
phorylated GST-NPM/wt and GST-NPM/T199D is dose
dependent (lane 9 vs. lane 10, lane 15 vs. lane 16, lane 17 vs. lane
18). Thus, NPM, when phosphorylated on Thr199 by CDK2,
acts as a suppressor of pre-mRNA splicing.4. Discussion
CDK2/cyclin E-mediated phosphorylation of NPM on
Thr199 has been shown to be a critical event in the initiation
of centrosome duplication [12,13]. In this study, we examined
whether CDK2/cyclin E (and A)-mediated phosphorylation of
NPM on Thr199 aﬀects biological events other than centro-
some duplication by the use of the antibody that speciﬁcally
recognizes phospho-Thr199 NPM. We found that phospho-
Thr199 NPM accumulates at nuclear speckles in parallel with
the well-established activation kinetics of CDK2/cyclin E and
A, in which CDK2/cyclin E is activated at late G1, and
CDK2/cyclin A during S and G2 phases of the cell cycle (re-
viewed in [37,53]). We further demonstrated that Thr199 phos-
phorylation targets NPM to the nuclear speckles. The nuclear
speckles are the site of assembly and/or storage of splicing fac-
tors, supplying splicing factors to the sites of transcription.
NPM re-localizes with authentic splicing factors such as
SC35 from the nuclear speckles upon forced inhibition of tran-
scription. NPM was co-puriﬁed with splicing activator in the
highly puriﬁed fractions of splicing-competent nuclear extracts
[25], and antibodies against several splicing factors, including
SF2/ASF and RNPS1, co-immunoprecipitates NPM. All these
ﬁndings point to the possibility that NPM associates with
splicing factors to regulate splicing in vivo. We found that
Thr199-phosphorylation of NPM dramatically enhances its
general RNA-binding activity. Moreover, in vitro splicing
reaction of b-globin pre-mRNA was signiﬁcantly repressed
when phospho-Thr199 NPM as well as phospho-Thr199 mi-
metic NPM mutant was added to the reaction. Together with
the previous ﬁnding, in which NPM induces changes in the sec-
ondary structure of RNA through physical interaction [15],
our ﬁndings strongly indicate that NPM is involved in the
pre-mRNA splicing process, which is controlled by Thr199
phosphorylation by CDK2/cyclin E (and A). At present, the
molecular mechanism underlying the repression of pre-mRNA
splicing by phospho-Thr199 NPM is not known, and we are
currently testing three possibilities. The enhanced RNA-bind-
ing activity of phospho-Thr199 NPMmay alter RNA structure,
making the splice sites less accessible to splicing complexes.
Alternatively, phospho-Thr199 NPM may inhibit the activities
of splicing factors through physical interaction. Third possibil-
ity is that NPM may be involved in assembly of spliceosome.
Spliceosome is a dynamic multiprotein/RNA complex, which
involves >200 diﬀerent proteins [54–56], and undergoes multi-
ple assembly steps and conformational changes. Considering
that NPM possesses a molecular chaperoning activity, NPM
may promote a proper assembly of spliceosomes at the site
of transcription, which is controlled by Thr199 phosphoryla-
tion by CDK2/cyclin E and A.
Finally, the cell cycle-dependent accumulation of phospho-
Thr199 NPM at nuclear speckles mediated by CDK2/cyclin E
(and A) and the involvement of phospho-Thr199 NPM in
pre-mRNA splicing process raise the interesting question
regarding to a possible link between pre-mRNA splicing and
408 P. Tarapore et al. / FEBS Letters 580 (2006) 399–409cell cycle progression. Indeed, there is growing evidence linking
these two events (reviewed in [57,58]). For instance, one of SR
protein like factor SRp38 (also known as SRrp40, TASR-2,
NSSR-1) was shown to act as a splicing repressor when
dephosphorylated during M phase, and it was suggested that
dephosphorylation of SRp38 plays a role in gene silencing dur-
ing mitosis [59]. It has also been shown that the mRNA level of
the SR protein, SRp20, is controlled in a cell cycle-dependent
manner and activated by the CDK2/cyclin E-regulated tran-
scription factor E2F [60]. Intriguingly, phospho-Thr199 NPM
appears to be present in not all nuclear speckles (detected by
anti-SC35 antibody): 70% of them are positive for phos-
pho-Thr199 NPM. This raises the possibility that there may
be pre-mRNA splicing active and inactive loci near the nuclear
speckles which are controlled in a cell cycle-dependent manner,
and phospho-Thr199 NPM may be involved in temporal tuning
of the pre-mRNA splicing activity in response to the cell cycle
progression.
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